916 related articles for article (PubMed ID: 32763657)
1. Possible mechanisms responsible for acute coronary events in COVID-19.
Sheth AR; Grewal US; Patel HP; Thakkar S; Garikipati S; Gaddam J; Bawa D
Med Hypotheses; 2020 Oct; 143():110125. PubMed ID: 32763657
[TBL] [Abstract][Full Text] [Related]
2. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
3. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
Kempuraj D; Selvakumar GP; Ahmed ME; Raikwar SP; Thangavel R; Khan A; Zaheer SA; Iyer SS; Burton C; James D; Zaheer A
Neuroscientist; 2020; 26(5-6):402-414. PubMed ID: 32684080
[TBL] [Abstract][Full Text] [Related]
4. Is a "Cytokine Storm" Relevant to COVID-19?
Sinha P; Matthay MA; Calfee CS
JAMA Intern Med; 2020 Sep; 180(9):1152-1154. PubMed ID: 32602883
[No Abstract] [Full Text] [Related]
5. Spectrum of Neurological Manifestations in Covid-19: A Review.
Garg RK
Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
[TBL] [Abstract][Full Text] [Related]
6. The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach.
Morris G; Bortolasci CC; Puri BK; Olive L; Marx W; O'Neil A; Athan E; Carvalho AF; Maes M; Walder K; Berk M
Life Sci; 2020 Oct; 258():118166. PubMed ID: 32739471
[TBL] [Abstract][Full Text] [Related]
7. [Progress on role of cytokine storm in exacerbation of coronavirus disease 2019 (COVID-19): Review].
Liao J; Wen B; Deng X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Oct; 36(10):941-947. PubMed ID: 33148390
[TBL] [Abstract][Full Text] [Related]
8. The Science Underlying COVID-19: Implications for the Cardiovascular System.
Liu PP; Blet A; Smyth D; Li H
Circulation; 2020 Jul; 142(1):68-78. PubMed ID: 32293910
[TBL] [Abstract][Full Text] [Related]
9. Itolizumab, an anti-CD6 monoclonal antibody, as a potential treatment for COVID-19 complications.
Loganathan S; Athalye SN; Joshi SR
Expert Opin Biol Ther; 2020 Sep; 20(9):1025-1031. PubMed ID: 32700604
[TBL] [Abstract][Full Text] [Related]
10. Cytokine Storm in COVID-19 Patients, Its Impact on Organs and Potential Treatment by QTY Code-Designed Detergent-Free Chemokine Receptors.
Mustafa MI; Abdelmoneim AH; Mahmoud EM; Makhawi AM
Mediators Inflamm; 2020; 2020():8198963. PubMed ID: 33029105
[TBL] [Abstract][Full Text] [Related]
11. The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of "inflame-aging".
Meftahi GH; Jangravi Z; Sahraei H; Bahari Z
Inflamm Res; 2020 Sep; 69(9):825-839. PubMed ID: 32529477
[TBL] [Abstract][Full Text] [Related]
12. The pathogenesis and treatment of the `Cytokine Storm' in COVID-19.
Ye Q; Wang B; Mao J
J Infect; 2020 Jun; 80(6):607-613. PubMed ID: 32283152
[TBL] [Abstract][Full Text] [Related]
13. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19.
Azkur AK; Akdis M; Azkur D; Sokolowska M; van de Veen W; Brüggen MC; O'Mahony L; Gao Y; Nadeau K; Akdis CA
Allergy; 2020 Jul; 75(7):1564-1581. PubMed ID: 32396996
[TBL] [Abstract][Full Text] [Related]
14. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme 2 (ACE2): COVID 19 gate way to multiple organ failure syndromes.
Loganathan S; Kuppusamy M; Wankhar W; Gurugubelli KR; Mahadevappa VH; Lepcha L; Choudhary AK
Respir Physiol Neurobiol; 2021 Jan; 283():103548. PubMed ID: 32956843
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 and rheumatology: is shielding really necessary?
Amani L; Warraich R; Patel N; Tahir H
Br J Hosp Med (Lond); 2020 Jun; 81(6):1-3. PubMed ID: 32589537
[TBL] [Abstract][Full Text] [Related]
17. Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin.
Alunno A; Carubbi F; Rodríguez-Carrio J
RMD Open; 2020 May; 6(1):. PubMed ID: 32423970
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2, which induces COVID-19, causes kawasaki-like disease in children: role of pro-inflammatory and anti-inflammatory cytokines.
Ronconi G; Teté G; Kritas SK; Gallenga CE; Caraffa Al; Ross R; Conti P
J Biol Regul Homeost Agents; 2020 May-June,; 34(3):767-773. PubMed ID: 32476380
[TBL] [Abstract][Full Text] [Related]
19. The Management of Cytokine Storm in COVID-19.
Rumende CM; Susanto EC; Sitorus TP
Acta Med Indones; 2020 Jul; 52(3):306-313. PubMed ID: 33020343
[TBL] [Abstract][Full Text] [Related]
20. The amount of cytokine-release defines different shades of Sars-Cov2 infection.
Bindoli S; Felicetti M; Sfriso P; Doria A
Exp Biol Med (Maywood); 2020 Jun; 245(11):970-976. PubMed ID: 32460624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
